We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCOR:NASDAQcomScore, Inc. Analysis

Data as of 2026-04-30 - not real-time

$7.56

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

comScore, Inc. (SCOR) trades at $7.56, comfortably above its 20‑day SMA of $7.44 and well above the 200‑day SMA of $7.05, indicating a short‑term bullish bias despite a bearish MACD histogram. RSI sits at 51.8, suggesting neutral momentum, while the stock sits near its calculated support of $6.64 and faces resistance around $8.72. The valuation metrics are strikingly cheap – a trailing P/E of 1.78 versus an industry average of 37.8 and a price‑to‑book of just 1.01 – positioning the share as potentially undervalued. However, fundamentals reveal challenges: revenue has slipped 1.6% YoY, profit margin is negative (-2.8%), and ROE is –5%, highlighting ongoing earnings pressure. The balance sheet shows $23.6 M in cash against $59.9 M of debt, yielding a modest debt‑to‑equity of 29.8%, which tempers liquidity concerns. Volatility is high at 72% over the past 30 days and beta is sub‑1 (0.83), implying the stock moves more than the market but with slightly lower systematic risk. The market sentiment is extremely bullish, reflected by a Fear & Greed Index reading of 87.84 (“Extreme Greed”), and analysts project a 32% upside based on the current price versus a $10 target. Recent material news cites new agreements with over 15 broadcast clients, underscoring growing demand for local measurement services and providing a catalyst for revenue uplift. Overall, the stock blends a compelling valuation edge with notable execution risks, making it a nuanced play for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMA but bearish MACD histogram
  • Neutral RSI and stable volume
  • Proximity to support level at $6.64

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (P/E 1.78 vs industry 37.8)
  • Upside potential of ~32% and extreme greed market sentiment
  • New client agreements expanding local measurement revenue

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative profit margins and declining revenue growth
  • Potential turnaround from strategic client wins
  • Modest leverage but limited cash relative to debt

Key Metrics & Analysis

Financial Health

Revenue Growth-1.60%
Profit Margin-2.80%
P/E Ratio1.8
ROE-5.00%
ROA0.67%
Debt/Equity29.76
P/B Ratio1.0
Op. Cash Flow$22.7M
Free Cash Flow$997.0K
Industry P/E37.8

Technical Analysis

TrendBullish
RSI51.8
Support$6.64
Resistance$8.72
MA 20$7.44
MA 50$7.23
MA 200$7.05
MACDBearish
VolumeStable
Fear & Greed Index87.84

Valuation

Target Price$10.00
Upside/Downside32.28%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.83
Volatility72.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.